ASPIRIN AND DIPYRIDAMOLE: Pharmaceutical manufacturers, suppliers, and wholesalers

Subscribe to access the full database, or Get Started Free
Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Amneal Pharms	ASPIRIN AND DIPYRIDAMOLE	aspirin; dipyridamole	CAPSULE, EXTENDED RELEASE;ORAL	206392	ANDA	AvKARE	42291-116-60	60 CAPSULE in 1 BOTTLE (42291-116-60)	2017-04-27
Amneal Pharms	ASPIRIN AND DIPYRIDAMOLE	aspirin; dipyridamole	CAPSULE, EXTENDED RELEASE;ORAL	206392	ANDA	Amneal Pharmaceuticals LLC	65162-596-06	60 CAPSULE in 1 BOTTLE (65162-596-06)	2016-03-28
Dr Reddys	ASPIRIN AND DIPYRIDAMOLE	aspirin; dipyridamole	CAPSULE, EXTENDED RELEASE;ORAL	209048	ANDA	NorthStar Rx LLC	16714-964-01	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (16714-964-01)	2019-04-03
Dr Reddys	ASPIRIN AND DIPYRIDAMOLE	aspirin; dipyridamole	CAPSULE, EXTENDED RELEASE;ORAL	209048	ANDA	Dr. Reddy's Laboratories Inc	43598-339-60	60 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (43598-339-60)	2018-10-10
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>NDA/ANDA	>Supplier	>Package Code	>Package	>Marketing Start

Last updated: August 11, 2025

Introduction

In the pharmaceutical industry, understanding the landscape of suppliers for key medications like aspirin and dipyridamole is vital for stakeholders including manufacturers, healthcare providers, and investors. Both drugs serve distinct therapeutic roles—aspirin as an analgesic, antipyretic, and antiplatelet agent, and dipyridamole primarily as an antithrombotic. Their supply chains involve a complex network of chemical manufacturers, intermediates suppliers, and formulation companies. This report delves into the primary suppliers, regional dynamics, and industry trends to inform strategic sourcing and competitive analysis.

Aspirin Supply Chain Overview

1. Raw Material Suppliers

Aspirin (acetylsalicylic acid) is synthesized chemically from salicylic acid, which is predominantly derived from plant sources such as willow bark and Populus species. Commercial production relies heavily on chemical synthesis using precursor chemicals like acetic anhydride, which are manufactured globally.

Major suppliers of raw materials:

Chemical Intermediates Producers: Companies such as BASF, Dow, and Evonik supply high-purity acetic anhydride and other specialty chemicals critical to aspirin synthesis. These intermediates are essential for large-scale pharmaceutical manufacturing.
Salicylic Acid Suppliers: Companies like Huaying Chemical (China), Sinclair (India), and BASF are key producers of pharmaceutical-grade salicylic acid. The Chinese market dominates in volume, with other regions supplying specialty or higher-purity grades.

2. Active Pharmaceutical Ingredient (API) Manufacturers

Aspirin APIs are produced primarily by large pharmaceutical and generic drug manufacturers:

Hoffmann-La Roche: Historically a pioneer in aspirin manufacture, Roche continues to supply pharmaceutical-grade aspirin globally, especially for branded formulations.
Sandoz (Novartis): A leading producer of aspirin APIs targeting generics markets worldwide.
Mochida Pharmaceutical: Based in Japan, supplies high-quality aspirin APIs for both domestic and export markets.
Indian Manufacturers: Firms like Sun Pharmaceutical Industries, Cipla, and Lupin have robust APIs production capabilities, frequently exporting to global markets.
Chinese Manufacturers: China’s Shanghai Xinyou Pharmaceutical and Hengkang Pharmaceutical produce large volumes of aspirin API, often at lower costs.

3. Contract Manufacturers and Repackagers

Several firms contract manufacturing to produce proprietary aspirin formulations from APIs:

Manufacturing Contractors: Contract manufacturing organizations (CMOs) such as Baxter BioPharma Solutions and regional CMOs in India and China produce finished dosage forms.

Dipyridamole Supply Chain Overview

1. Raw Material and API Sources

Dipyridamole (Persantine) is a synthetic antiplatelet agent developed in the mid-20th century. Its supply chain is more niche compared to aspirin, with fewer global producers.

API Manufacturers:
- Mochida Pharmaceutical (Japan): A leading supplier of dipyridamole API.
- Teva Pharmaceuticals (Israel): Offers dipyridamole APIs and formulations.
- Sinclair (India): Supplies dipyridamole API to regional markets.
- Chinese Manufacturers: Companies like Harbin Pharmaceutical Group and Shandong Xinhua Pharmaceutical produce dipyridamole API for domestic use and export.
Raw Material Suppliers: The synthesis of dipyridamole involves complex heterocyclic intermediates sourced from specialty chemical suppliers, primarily in China and India.

2. Finished Dosage Form Manufacturers

Formulation capacity is concentrated in Asia:

Indian firms such as Cipla and Sun Pharmaceutical produce generic dipyridamole tablets for international markets.
European and US Markets: Generally depend on imports from Asian manufacturers, with limited in-region production due to regulatory and market size factors.

3. Regulatory and Supply Considerations

Dipyridamole’s supply chain has been impacted by regulatory scrutiny and market demand fluctuations. Manufacturing quality standards governed by the US Food and Drug Administration (FDA) and EMA drive sourcing decisions, often favoring manufacturers with proven compliance.

Regional Dynamics and Market Trends

1. Asia’s Dominance

China and India are primary suppliers for both aspirin and dipyridamole, benefiting from lower manufacturing costs and extensive chemical manufacturing infrastructure. China, in particular, accounts for a significant share of global raw materials and APIs due to its large chemical complexes.

2. Regulatory Impact

Stringent regulatory standards, particularly from the FDA and EMA, influence supplier reliability and quality assurance. Companies that achieve Good Manufacturing Practice (GMP) certification and environmental compliance tend to have a competitive advantage.

3. Supply Chain Risks

Reliance on regional producers poses risks including geopolitical tensions, export restrictions, and quality variability. Disruptions such as the COVID-19 pandemic underscored the need for diversified sourcing strategies.

4. Strategic Sourcing Trends

There is an increasing trend toward vertical integration, with pharmaceutical firms investing in their manufacturing capacity or establishing long-term agreements with reliable suppliers. Some companies are exploring alternative sourcing for raw materials to mitigate geopolitical and regulatory risks.

Competitive Landscape and Market Players

Major players dominate the supply of aspirin and dipyridamole:

Drug	Key Suppliers	Region	Market Position
Aspirin	Hoffmann-La Roche, Sandoz, Huaying Chemical, Indian generic manufacturers	Global	Leaders in both branded and generic markets
Dipyridamole	Mochida Pharmaceutical, Teva, Sinclaire, Chinese manufacturers	Asia, Europe	Niche but steady supply, regional dominance

Strategic partnerships, licensing agreements, and capacity expansions continually shape the competitive landscape.

Regulatory and Intellectual Property Considerations

While aspirin’s patent has long expired, enabling broad generic manufacturing, dipyridamole’s patent expiry and regulatory approvals in various jurisdictions facilitate global supply but also engender quality variation concerns. Regulatory compliance is essential for market access and supply continuity, especially in regulated markets like the US and Europe.

Conclusion

The supply of aspirin and dipyridamole hinges on a global network of chemical intermediates suppliers, API producers, and formulation manufacturers, predominantly centered in Asia. Major multinational firms like Hoffmann-La Roche and Sandoz lead aspirin production, while specialized firms such as Mochida and Teva remain critical for dipyridamole. Dependence on regional suppliers presents ongoing risks, prompting industry consolidation and diversification efforts.

Key Takeaways

Global dependence on Asian suppliers—particularly China and India—for raw materials and APIs necessitates risk mitigation strategies.
Regulatory compliance remains a critical determinant of supplier reliability and market access—certifications like GMP and ISO are essential.
Vertical integration and strategic partnerships are increasingly prioritized by pharmaceutical companies seeking supply security.
Market dynamics favor generic manufacturers with established chemistry and manufacturing infrastructure, especially in regions with favorable regulatory environments.
Supply disruptions can substantially impact drug availability; diversification and supply chain resilience are vital.

FAQs

1. Who are the leading global suppliers of aspirin API?
Hoffmann-La Roche, Sandoz (a Novartis division), and Indian companies like Sun Pharma and Cipla are key API suppliers, along with Chinese manufacturers such as Shanghai Xinyou Pharmaceutical.

2. How is dipyridamole primarily sourced?
Mainly from Japanese, Indian, and Chinese manufacturers, with a limited number of global suppliers producing both APIs and finished formulations.

3. What are the risks associated with aspirin and dipyridamole supply chains?
Risks include geopolitical tensions, quality variability, environmental regulation compliance, and global disruptions like pandemics affecting manufacturing and logistics.

4. Are there ongoing efforts to diversify sourcing for these drugs?
Yes. Pharmaceutical firms are increasingly establishing regional manufacturing facilities, forming long-term supplier agreements, and investing in alternate chemical pathways.

5. How do regulatory standards influence supplier choices?
Strict adherence to GMP and other global compliance standards is essential; regulators prioritize suppliers with validated manufacturing processes, impacting procurement decisions significantly.

References

[1] U.S. Food and Drug Administration (FDA), “APIs and Manufacturing,” 2022.
[2] European Medicines Agency (EMA), “Guidelines on Good Manufacturing Practice,” 2022.
[3] MarketWatch, “Global Aspirin Market Analysis,” 2023.
[4] IMS Health, “Global API Supply Chain Report,” 2022.
[5] Industry Reports, “Dipyridamole and Aspirin Market Trends,” 2023.

Suppliers and packagers for ASPIRIN AND DIPYRIDAMOLE